Research results mean different things to the different sides of the argument about oral phenylephrine’s efficacy as a nasal decongestant, a discussion which could decide whether the ingredient remains available for the indication in the US under an OTC monograph.
During the first day of a two-day meeting of the Food and Drug Administration’s Nonprescription Drugs Advisory Committee on 11...







